Clinical Trial Update: PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating a PD-1 inhibitor plus chemotherapy, followed by immediate versus salvage locoregional radiotherapy in patients with de novo metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharangeal Cancer, Distant Metastasis | Phase 3 | Status: RECRUITING